👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

LifeMD shares get Buy rating at Lake Street Capital amid rapid growth

EditorRachael Rajan
Published 10/12/2024, 14:24
LFMD
-

On Tuesday, Lake Street Capital Markets initiated coverage on LifeMD Inc (NASDAQ: LFMD), assigning a Buy rating and establishing a price target of $12.00.

LifeMD, recognized as a leading provider in the virtual primary care space, offers telemedicine services and access to laboratory and pharmacy services. The company covers an extensive range of treatments, including primary care, men’s and women’s health, weight management, and hormone therapy.

The company has been actively expanding its capabilities and infrastructure. Recently, LifeMD opened a new 22,000 square foot pharmacy and has been broadening commercial insurance coverage for its patients. Expectations are set for Medicare coverage to become available in 2025. Additionally, LifeMD has expanded its RexMD men’s health offering to include hormone therapy.

"LifeMD is committed to becoming the leading provider of virtual healthcare across a range of categories and capabilities. We believe the Company™s platform is both timely and scalable," said analysts at Lake Street Capital.

In the third quarter, the company reported a 38% increase in revenue, reaching $53.4 million. Gross margin improved significantly to 90.6%, up from 87.6% in the previous year. The number of active telehealth subscribers also saw a substantial rise, growing 30% to approximately 269,000.

The company's weight management offering, which includes GLP-1 medications, is particularly noteworthy for its vast market potential. Lake Street Capital Markets sees this as a key driver for LifeMD's future growth. The firm anticipates continued rapid growth, increasing margins, and a clear path to profitability for LifeMD, projected for 2025 or 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.